The downregulation of p-PI3K and p-AKT confirms suppression of survival signaling, while the inhibition of key oncogenic regulators AKT1, MTOR, HIF1A, SRC, and ESR1 suggests broader effects on tumor metabolism, hypoxia adaptation, and growth factor receptor pathways. Here, ESR1 is linked to neoplasm.